First AREDS 2 AMD product hits market

Article

Visual Advantage by Macular Health is the first product available to the public featuring the new AREDS 2 formula for preventing vision loss due to AMD.

 

Birmingham, AL-Visual Advantage by Macular Health has become the first product available to the public featuring the new AREDS 2 formula for preventing vision loss due to AMD.

Macular Health's original supplement formulation was modeled after the results of AREDS I, released in 2001. However, Jeffery McAnnally, president and chief executive officer of Macular Health, along with John O. Mason, III, MD, a retina surgeon from the University of Alabama at Birmingham Callahan Eye Foundation Hospital, modified the formula slightly to include lutein and zeaxanthin, which were ultimately proven by AREDS 2 to be the keys to the supplement's effectiveness.

Macular Health's Visual Advantage is specially formulated in the United States by an FDA inspected and GMP (Good Manufacturing Practices) compliant facility.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jade Coats, OD, FAAO, gives her insight on what makes EyeCon valuable for eye care providers.
Allen, OD, FAAO, Dipl ABO, plans to talk all things ocular surface for optometrists and ophthalmologists alike.
Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz
© 2025 MJH Life Sciences

All rights reserved.